Live feed
Filing
SC 13G/A
SC 13G/A0000902219-20-000050·Revance Therapeutics, Inc.
Schedule 13G ownership disclosure
REVANCE THERAPEUTICS INC
Security class unavailable · CUSIP: 761330109
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,788,045
- Percent of class
- 11.4400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-20-000050
- Form type
- SC 13G/A
- Filer
- Revance Therapeutics, Inc.
- CIK
- CIK 1479290
- Filed
- Jan 08, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership